Ibuprofen is a medication commonly used to reduce pain and inflammation, but a new study suggests its benefits do not stop there. Researchers have found that the drug may also reduce the risk of death from lung cancer among former and current smokers.
MEK inhibitor selumetinib in combination with docetaxel does not improve progression free or overall survival in individuals with KRAS-mutant non-small-cell lung cancer (NSCLC), according to data presented at the ESMO 2016 Congress in Copenhagen1.
It is estimated that more than 158,000 people in the US will die from lung cancer this year, emphasizing the need for earlier detection of the disease, leading to better treatment outcomes. Now, researchers have discovered a biomarker that could lead to a highly accurate blood test for early detection of nonsmall cell lung cancer – the most common form of the disease.
It is well known that mutations in the BRCA genes increase the risk of female breast and ovarian cancers. But for the first time, researchers from The Institute of Cancer Research in the UK have discovered a link between smokers with a BRCA2 gene mutation and increased risk of lung cancer. Read more